Abstract
Nitrite has long been considered an inert oxidative metabolite of nitric oxide (NO). However, recent experimental findings strongly suggest that nitrite is a critical storage form of NO that is converted back into NO during ischemic or hypoxic events as well as under physiological conditions. Thus, the conversion of nitrite into NO during cellular stress may be an evolutionarily conserved and redundant means for NO generation at a time when endothelial nitric oxide synthase is non-functional. As a result of the recent revelation that the nitrite anion serves an important biological function a large number of studies have been performed to characterize both the physiological actions and therapeutic potential of nitrite under diverse conditions. While the earliest experiments characterized the vasodilatory effects of nitrite in both animal models and humans, more recent research efforts have focused on the potential benefits of nitrite in a number of pathological states. Nitrite therapy has now been studied in numerous animal models and has proven to be an effective means to ameliorate myocardial ischemia-reperfusion (I/R) injury. This review will focus on recent experimental findings related to the cytoprotective actions of nitrite therapy in the setting of myocardial I/R injury.
Similar content being viewed by others
References
Alikulov, Z. A., L’Vov, N. P., and Kretovich, V. L., Nitrate and nitrite reductase activity of milk xanthine oxidase. Biokhimiia, 45, 1714–1718 (1980).
Bolli, R., Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J. Mol. Cell. Cardiol., 33, 1897–1911 (2001).
Brunori, M., Nitric oxide moves myoglobin centre stage. Trends Biochem. Sci., 26, 209–210 (2001).
Bryan, N. S., Calvert, J. W., Elrod, J. W., Gundewar, S., Ji, S. Y., and Lefer, D. J., Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA, 104, 19144–19149 (2007).
Bryan, N. S., Calvert, J. W., Gundewar, S., and Lefer, D. J., Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice. Free Radic. Biol. Med., 45, 468–474 (2008).
Bryan, N. S., Fernandez, B. O., Bauer, S. M., Garcia-Saura, M. F., Milsom, A. B., Rassaf, T. et al., Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol., 1, 290–297 (2005).
Bryan, N. S., Rassaf, T., Maloney, R. E., Rodriguez, C. M., Saijo, F., Rodriguez, J. R. et al., Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. U S A, 101, 4308–4313 (2004).
Bryan, N. S., Nitrite in nitric oxide biology: cause or consequence? A systemsbased review. Free Radic. Biol. Med., 41, 691–701 (2006).
Cai, H. and Harrison, D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res., 87, 840–844 (2000).
Calvert, J. W. and Lefer, D. J., Statin therapy and myocardial no-reflow. Br. J. Pharmacol., 149, 229–231 (2006).
Cannon, R. O. 3rd, Schechter, A. N., Panza, J. A., Ognibene, F. P., Pease-Fye, M. E., Waclawiw, M. A. et al., Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J. Clin. Invest., 108, 279–287 (2001).
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S. et al., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med., 9, 1498–1505 (2003).
Depre, C., Vanoverschelde, J. L., Goudemant, J. F., Mottet, I., and Hue, L., Protection against ischemic injury by non-vasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation, 92, 1911–1918 (1995).
Dezfulian, C., Raat, N., Shiva, S., and Gladwin, M. T., Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc. Res., 75, 327–338 (2007).
Dudzinski, D. M., Igarashi, J., Greif, D., and Michel, T., The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol., 46, 235–276 (2006).
Duranski, M. R., Greer, J. J., Dejam, A., Jaganmohan, S., Hogg, N., Langston, W. et al., Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest., 115, 1232–1240 (2005).
Elrod, J. W., Calvert, J. W., Gundewar, S., Bryan, N. S., and Lefer, D. J., Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide. Proc. Natl. Acad. Sci. U S A, 105, 11430–11435 (2008).
Elrod, J. W., Greer, J. J., Bryan, N. S., Langston, W., Szot, J. F., Gebregzlabher, H. et al., Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol., 26, 1517–1523 (2006).
Elrod, J. W., Greer, J. J., and Lefer, D. J., Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway. Am. J. Physiol., 292, H342–347 (2007).
Ferdinandy, P. and Schulz, R., Nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning. Br. J. Pharmacol., 138, 532–543 (2003).
Flogel, U., Godecke, A., Klotz, L. O., and Schrader, J., Role of myoglobin in the antioxidant defense of the heart. FASEB J., 18, 1156–1158 (2004).
Fox-Robichaud, A., Payne, D., Hasan, S. U., Ostrovsky, L., Fairhead, T., Reinhardt, P. et al., Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J. Clin. Invest., 101, 2497–2505 (1998).
Funai, E. F., Davidson, A., Seligman, S. P., and Finlay, T. H., S-nitrosohemoglobin in the fetal circulation may represent a cycle for blood pressure regulation. Biochem. Biophys. Res. Commun., 239, 875–877 (1997).
Furchgott, R. F., Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci. Rep., 19, 235–251 (1999).
Gladwin, M. T., Raat, N. J., Shiva, S., Dezfulian, C., Hogg, N., Kim-Shapiro, D. B. et al., Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am. J. Physiol., 291, H2026–2035 (2006).
Gladwin, M. T., Schechter, A. N., Kim-Shapiro, D. B., Patel, R. P., Hogg, N., Shiva, S. et al., The emerging biology of the nitrite anion. Nat. Chem. Biol., 1, 308–314 (2005).
Gonzalez, F. M., Shiva, S., Vincent, P. S., Ringwood, L. A., Hsu, L. Y., Hon, Y. Y. et al., Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation, 117, 2986–2994 (2008).
Harrison, D. G., Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding? J. Clin. Invest., 91, 1–2 (1993).
Hataishi, R., Rodrigues, A. C., Neilan, T. G., Morgan, J. G., Buys, E., Shiva, S. et al., Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am. J. Physiol., 291, H379–H384 (2006).
Heiss, C., Lauer, T., Dejam, A., Kleinbongard, P., Hamada, S., Rassaf, T. et al., Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J. Am. Coll. Cardiol., 47, 573–579 (2006).
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., and Munzel, T., Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation, 104, 2673–2678 (2001).
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M. et al., Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res., 88, E14–22 (2001).
Hogg, N., Broniowska, K. A., Novalija, J., Kettenhofen, N. J., Novalija, E., Role or SNitrosothiol transport in the cardioprotective effects of S-Nitrosocysteine in rat hearts. Free Radic. Biol. Med., 2007.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G., Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U S A, 84, 9265–9269 (1987).
Ignarro, L. J., Edwards, J. C., Gruetter, D. Y., Barry, B. K., and Gruetter, C. A., Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett., 110, 275–278 (1980).
Ignarro, L. J. et al., Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: Evidence for the involvement of s-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther., 218, 739–749 (1981).
Ignarro, L. J., Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci. Rep., 19, 51–71 (1999).
Johnson, G. 3rd, Tsao, P. S., Mulloy, D., and Lefer, A. M., Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J. Pharmacol. Exp. Ther., 252, 35–41 (1990).
Jones, S. P. and Bolli, R., The ubiquitous role of nitric oxide in cardioprotection. J. Mol. Cell. Cardiol., 40, 16–23 (2006).
Jones, S. P., Girod, W. G., Palazzo, A. J., Granger, D. N., Grisham, M. B., Jourd’Heuil, D. et al., Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am. J. Physiol., 276, H1567–H1573 (1999).
Jones, S. P., Greer, J. J., Kakkar, A. K., Ware, P. D., Turnage, R. H., Hicks, M. et al., Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am. J. Physiol., 286, H276–H282 (2004).
Jugdutt, B. I., Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail. Rev., 7, 391–405 (2002).
Kelm, M. and Schrader, J., Control of coronary vascular tone by nitric oxide. Circ. Res., 66, 1561–1575 (1990).
Kelm, M., Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta., 1411, 273–289 (1999).
Kim, Y. M., Talanian, R. V., and Billiar, T. R., Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem., 272, 31138–31148 (1997).
Kleinbongard, P., Dejam, A., Lauer, T., Jax, T., Kerber, S., Gharini, P. et al., Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic. Biol. Med., 40, 295–302 (2006).
Kleinbongard, P., Dejam, A., Lauer, T., Rassaf, T., Schindler, A., Picker, O. et al., Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic. Biol. Med., 35, 790–796 (2003).
Kozlov, A. V., Staniek, K., and Nohl, H., Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett., 454, 127–130 (1999).
Kubes, P., Payne, D., Grisham, M. B., Jourd-Heuil, D., and Fox-Robichaud, A., Inhaled NO impacts vascular but not extravascular compartments in postischemic peripheral organs. Am. J. Physiol., 277, H676–H682 (1999).
Kukreja, R., Salloum, F., and Xi, L., Anti-ischemic effects of sildenafil, vardenafil and tadalafil in heart. Int. J. Impot. Res., 19, 226–227 (2007).
Kukreja, R. C., Ockaili, R., Salloum, F., and Xi, L., Sildenafil-induced cardioprotection in rabbits. Cardiovasc. Res., 60, 700–701; author reply 702–703 (2003).
Lauer, T., Preik, M., Rassaf, T., Strauer, B. E., Deussen, A., Feelisch, M. et al., Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc. Natl. Acad. Sci. USA, 98, 12814–12819 (2001).
Lefer, A. M., Campbell, B., Shin, Y. K., Scalia, R, Hayward, R., and Lefer, D. J., Simvastatin preserves the ischemicreperfused myocardium in normocholesterolemic rat hearts. Circulation, 100, 178–184 (1999).
Lefer, A. M. and Lefer, D. J., Pharmacology of the endothelium in ischemiareperfusion and circulatory shock. Annu. Rev. Pharmacol. Toxicol., 33, 71–90 (1993).
Lefer, D. J., Scalia, R., Jones, S. P., Sharp, B. R., Hoffmeyer, M. R., Farvid, A. R. et al., HMG-CoA reductase inhibition protects the diabetic myocardium from ischemiareperfusion injury. FASEB J., 15, 1454–1456 (2001).
Lefer, D. J., Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion. New. Horiz., 3, 105–112 (1995).
Lefer, D. J., Nitrite therapy for protection against ischemiareperfusion injury. Am. J. Physiol. Renal. Physiol., 290, F777–F778 (20060.
Li, H., Samouilov, A., Liu, X., and Zweier, J. L.. Characterization of the effects of oxygen on xanthine oxidasemediated nitric oxide formation. J. Biol. Chem., 279, 16939–16946 (2004).
Li, J., Bombeck, C. A., Yang, S., Kim, Y. M., Billiar, T. R., Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J. Biol. Chem., 274, 17325–17333 (1999).
Liu, X., Miller, M. J., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., and Lancaster, J. R. Jr., Diffusionlimited reaction of free nitric oxide with erythrocytes. J. Biol. Chem., 273, 18709–18713 (1998).
Loke, K. E., Laycock, S. K., Mital, S., Wolin, M. S., Bernstein, R., Oz, M. et al., Nitric oxide modulates mitochondrial respiration in failing human heart. Circulation, 100, 1291–1297 (1999).
Loscalzo, J. and Welch, G., Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis., 38, 87–104 (1995).
Lundberg, J. O. and Govoni, M., Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic. Biol. Med., 37, 395–400 (2004).
Lundberg, J. O., Weitzberg, E., Cole, J. A., and Benjamin, N., Nitrate, bacteria and human health. Nat. Rev. Microbiol., 2, 593–602 (2004).
Lundberg, J. O. and Weitzberg, E., NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol., 25, 915–922 (2005).
Ma, X. L., Weyrich, A. S., Lefer, D. J., and Lefer, A. M., Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res., 72, 403–412 (1993).
Matheis, G., Sherman, M. P., Buckberg, G. D., Haybron, D. M., Young, H. H., and Ignarro, L. J., Role of L-argininenitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol., 262, H616–H620 (1992).
Michel, T. and Feron, O., Nitric oxide synthases: which, where, how, and why? J. Clin. Invest., 100, 2146–2152 (1997).
Mori, E., Haramaki, N., Ikeda, H., and Imaizumi, T., Intracoronary administration of Larginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc. Res., 40, 113–123 (1998).
Murad, F., Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N. Engl. J. Med., 355, 2003–2011 (2006).
Naseem, S. A., Kontos, M. C., Rao, P. S., Jesse, R. L., Hess, M. L., and Kukreja, R. C., Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J. Mol. Cell. Cardiol., 27, 419–426 (1995).
Ng, E. S., Jourd’heuil, D., McCord, J. M., Hernandez, D., Yasui, M., Knight, D. et al., Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ. Res., 94, 559–565 (2004).
Pabla, R., Buda, A. J., Flynn, D. M., Blesse, S. A., Shin, A. M., Curtis, M. J. et al., Nitric oxide attenuates neutrophilmediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res., 78, 65–72 (1996).
Palmer, R. M., Ferrige, A. G., and Moncada, S., Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature, 327, 524–526 (1987).
Quezado, Z. M., Natanson, C., Karzai, W., Danner, R. L., Koev, C. A., Fitz, Y. et al., Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. J. Appl. Physiol., 84, 107–115 (19980.
Rassaf, T., Flogel, U., Drexhage, C., Hendgen-Cotta, U., Kelm, M., and Schrader, J., Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ. Res., 100, 1749–1754 (2007).
Rassaf, T., Preik, M., Kleinbongard, P., Lauer, T., Heiss, C., Strauer, B. E. et al., Evidence for in vivo transport of bioactive nitric oxide in human plasma. J. Clin. Invest., 109, 1241–1248 (2002).
Reutov, V. P. and Sorokina, E. G., NO-synthase and nitritereductase components of nitric oxide cycle. Biochemistry (Mosc), 63, 874–884 (1998).
Samouilov, A., Kuppusamy, P., and Zweier, J. L., Evaluation of the magnitude and rate of nitric oxide production from nitrite in biological systems. Arch. Biochem. Biophys., 357, 1–7 (1998).
Scalia, R., Gooszen, M. E., Jones, S. P., Hoffmeyer, M., Rimmer, D. M. 3rd, Trocha, S. D. et al., Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation, 103, 2598–2603 (2001).
Schulz, R., Kelm, M., and Heusch, G., Nitric oxide in myocardial ischemia/reperfusion injury. Card. Res., 61, 402–413 (2004).
Sessa, W. C., eNOS at a glance. J. Cell Sci., 117, 2427–2429 (2004).
Sharp, B. R., Jones, S. P., Rimmer, D. M., and Lefer, D. J., Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am. J. Physiol., 282, H2422–2426 (2002).
Shiva, S., Sack, M. N., Greer, J. J., Duranski, M., Ringwood, L. A., Burwell, L. et al., Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med., 204, 2089–2102 (2007a).
Shiva, S., Huang, Z., Grubina, R., Sun, J., Ringwood, L. A., MacArthur, P. H. et al., Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res., 100, 654–661 (2007b).
Siegfried, M. R., Carey, C., Ma, X. L., and Lefer, A. M., Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am. J. Physiol., 263, H771–H777 (1992).
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J. et al., Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serumn albumin. Proc. Natl. Acad. Sci. U S A, 89, 7674–7677 (1992).
Takahashi, Y., Kobayashi, H., Tanaka, N., Sato, T., Takizawa, N., and Tomita, T.. Nitrosyl hemoglobin in blood of normoxic and hypoxic sheep during nitric oxide inhalation. Am. J. Physiol., 274, H349–357 (1998).
Thomas, D. D., Liu, X., Kantrow, S. P., and Lancaster, J. R. Jr., The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc. Natl. Acad. Sci. USA, 98, 355–360 (2001).
Troncy, E., Francoeur, M., Salazkin, I., Yang, F., Charbonneau, M., Leclerc, G. et al., Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Br. J. Anaesth., 79, 631–640 (1997).
Walters, C. L., Casselden, R. J., and Taylor, A. M., Nitrite metabolism by skeletal muscle mitochondria in relation to haem pigments. Biochim. Biophys. Acta., 143, 310–318 (1967).
Wang, D., Yang, X. P., Liu, Y. H., Carretero, O. A., La-Pointe, M. C., Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am. J. Hypertens., 12, 174–182 (1999).
Webb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N., and Ahluwalia, A., Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemiareperfusion damage. Proc. Natl. Acad. Sci. USA, 101, 13683–13688 (2004).
Wittenberg, J. B. and Wittenberg, B. A., Myoglobin function reassessed. J. Exp. Biol., 206, 2011–2020 (2003).
Yasmin, W., Strynadka, K. D., and Schulz, R., Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res., 33, 422–432 (1997).
Zuzak, K. J., Schaeberle, M. D., Gladwin, M. T., Cannon, R. O. 3rd, and Levin, I. W., Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique. Circulation, 104, 2905–2910 (2001).
Zweier, J. L., Samouilov, A., and Kuppusamy, P., Nonenzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta., 1411, 250–262 (1999).
Zweier, J. L., Wang, P., Samouilov, A., and Kuppusamy, P., Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med., 1, 804–809 (1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lefer, D.J. Emerging role of nitrite in myocardial protection. Arch. Pharm. Res. 32, 1127–1138 (2009). https://doi.org/10.1007/s12272-009-1804-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1804-y